Edward Dulac

Edward Dulac

Director of Finance/CFO at FATE THERAPEUTICS, INC.

Net worth: 41 734 $ as of 2024-04-29

49 year
Consumer Services
Health Technology
Finance

Profile

Currently, Edward J. Dulac occupies the position of Chief Financial Officer & Accounting Officer at Fate Therapeutics, Inc. In the past he was Principal at CVS, Inc. (Maryland), Vice President-Business Development & Strategy at Celgene Corp., Principal at Pfizer (St. Louis), Principal at Brooks Eckerd Pharmacy, Research Analyst at Barclays Capital, Inc. and Research Analyst at Barclays Capital Securities Ltd. He received an undergraduate degree from the University of Pittsburgh and an MBA from Kelley School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-30 10,784 ( 0.01% ) 41 734 $ 2024-04-29

Edward Dulac active positions

CompaniesPositionStart
FATE THERAPEUTICS, INC. Director of Finance/CFO 2020-08-16
All active positions of Edward Dulac

Former positions of Edward Dulac

CompaniesPositionEnd
CELGENE Corporate Officer/Principal 2020-01-31
Analyst-Equity 2011-07-24
Corporate Officer/Principal 2007-11-29
Brooks Eckerd Pharmacy Corporate Officer/Principal 2001-06-29
Corporate Officer/Principal 1999-09-29
See the detail of Edward Dulac's experience

Training of Edward Dulac

University of Pittsburgh Undergraduate Degree
Kelley School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Edward Dulac's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
FATE THERAPEUTICS, INC.

Health Technology

Private companies6

Finance

Finance

Consumer Services

Brooks Eckerd Pharmacy

Health Technology

Health Technology

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW